We are very pleased to present you with the latest installment of our comment letter trends publication in which we analyze recent SEC comment letters in the Health Industries sector. We analyzed over 1,400 comments received by Pharmaceutical & Lifesciences and Health services companies in the past year.
This publication focuses on what key stakeholders value in your disclosures, and will assist you with your SEC reporting by providing a summary of the most recent comment letter trends.
Our review of the comment letters indicates a focus by the SEC staff on transparent and accurate financial reporting through clear discussion in the MD&A, an understanding of revenue recognition policies, and compliance with SEC rules, including those pertaining to non-GAAP measures.
We hope that you find the insights useful in navigating your upcoming financial reports and the year-end reporting process. Please feel free to contact your PwC engagement team, the contacts listed at the back of this publication, or us to discuss the information in this publication or to address any questions you may have.
© 2016 - 2017 PwC. All rights reserved. PwC refers to the US member firm or one of its subsidiaries or affiliates, and may sometimes refer to the PwC network. Each member firm is a separate legal entity. Please see www.pwc.com/structure for further details.